Allelic and copy-number variations of FcγRs affect granulocyte function and susceptibility for autoimmune blistering diseases

Journal of Autoimmunity

Volumn 61, Issue , 2015, Pages 36-44

  Recke, Andreas ^a   Vidarsson, Gestur ^b   Ludwig, Ralf J ^a   Freitag, Miriam ^a   Möller, Steffen ^a   Vonthein, Reinhard ^a,c   Schellenberger, Julia ^a   Haase, Ozan ^a   Görg, Siegfried ^a   Nebel, Almut ^d   Flachsbart, Friederike ^d   Schreiber, Stefan ^d   Lieb, Wolfgang ^d   Gläser, Regine ^d   Benoit, Sandrine ^e   Sárdy, Miklós ^f   Eming, Rüdiger ^g   Hertl, Michael ^b   Zillikens, Detlef ^a   König, Inke R ^c   Schmidt, Enno ^a   Ibrahim, Saleh ^a   Däschlein, Georg ^h   Goebeler, Mattias ^e   Goetze, Steven ⁱ   Günther, Claudia ^j   Hadaschik, Eva ^k   Homey, Bernhard ^l   Hunzelmann, Nicolas ^m   Kreuter, Andreas ⁿ   Kunz, Manfred ^o   Lippert, Undine ^p   Ludwig Peitsch, Wiebke ^q   Pföhler, Claudia ^r   MiklosSardy ^f   Sticherling, Michael ^s   Worm, Margitta ^t   more..

^a UNIVERSITY OF LÜBECK   (Germany)

^b SANQUIN RESEARCH   (Netherlands)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g PHILIPPS UNIVERSITY MARBURG   (Germany)

^h UNIVERSITY OF GREIFSWALD   (Germany)

ⁱ JENA UNIVERSITY HOSPITAL   (Germany)

^j UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^k UNIVERSITY OF HEIDELBERG   (Germany)

^l HEINRICH HEINE UNIVERSITY   (Germany)

^m UNIVERSITY OF COLOGNE   (Germany)

ⁿ RUHR UNIVERSITY BOCHUM   (Germany)

^o UNIVERSITY OF LEIPZIG   (Germany)

^p DESSAU MEDICAL CENTER   (Germany)

^q UNIVERSITY OF HEIDELBERG   (Germany)

^r SAARLAND UNIVERSITY   (Germany)

^s UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^t CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

Autoantibodies; Autoimmune blistering dermatoses; Fc receptors; Functional genetics; Joint copy number and allelic variation; Neutrophils; Reactive oxygen species

Indexed keywords

AUTOANTIBODY; FC RECEPTOR; GENOMIC DNA; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; FCGR3A PROTEIN, HUMAN; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; AUTOIMMUNE BLISTERING DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNE SKIN DISEASE; BULLOUS PEMPHIGOID; CHILD; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE PREDISPOSITION; FEMALE; FUNCTIONAL GENETICS; GENE DOSAGE; GENE EXPRESSION; GENOTYPE; GRANULOCYTE FUNCTION; HUMAN; HUMAN CELL; HUMAN GENETICS; INFANT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NEUTROPHIL; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; VERY ELDERLY; YOUNG ADULT; BLISTER; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GRANULOCYTE; IMMUNOLOGY; METABOLISM; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; BLISTER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GPI-LINKED PROTEINS; GRANULOCYTES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; REACTIVE OXYGEN SPECIES; RECEPTORS, IGG;

EID: 84937515913     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2015.05.004     Document Type: Article

References (59)

1. Nimmerjahn F., Ravetch J.V. Fcgamma receptors: old friends and new family members. Immunity 2006, 24:19-28. 10.1016/j.immuni.2005.11.010.
2. Mihai S., Nimmerjahn F. The role of Fc receptors and complement in autoimmunity. Autoimmun. Rev. 2013, 12:657-660. 10.1016/j.autrev.2012.10.008.
3. Bruhns P., Iannascoli B., England P., Mancardi D.A., Fernandez N., Jorieux S., et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 2009, 113:3716-3725. 10.1182/blood-2008-09-179754.
4. Hogarth P.M. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr. Opin. Immunol. 2002, 14:798-802.
5. Zhao M., Trimbeger M.E., Li N., Diaz L.A., Shapiro S.D., Liu Z. Role of FcRs in animal model of autoimmune bullous pemphigoid. J.Immunol. 2006, 177:3398-3405.
6. Kasperkiewicz M., Nimmerjahn F., Wende S., Hirose M., Iwata H., Jonkman M.F., et al. Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury. J.Pathol. 2012, 228:8-19. 10.1002/path.4023.
7. Schmidt E., Zillikens D. Pemphigoid diseases. Lancet 2013, 381:320-332. 10.1016/S0140-6736(12)61140-4.
8. Takai T. Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol. 2002, 2:580-592. 10.1038/nri856.
9. Nimmerjahn F., Ravetch J.V. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 2008, 8:34-47. 10.1038/nri2206.
10. Bruhns P. Properties of mouse and human IgG receptors and their contribution to disease models. Blood 2012, 119:5640-5649. 10.1182/blood-2012-01-380121.
11. David A., Fridlich R., Aviram I. The presence of membrane proteinase 3 in neutrophil lipid rafts and its colocalization with FcgammaRIIIb and cytochrome b558. Exp. Cell Res. 2005, 308:156-165. 10.1016/j.yexcr.2005.03.034.
12. Vidarsson G., van de Winkel J.G. Fc receptor and complement receptor-mediated phagocytosis in host defence. Curr. Opin. Infect. Dis. 1998, 11:271-278.
13. Huizinga T.W., van der Schoot C.E., Jost C., Klaassen R., Kleijer M., von dem Borne A.E., et al. The PI-linked receptor FcRIII is released on stimulation of neutrophils. Nature 1988, 333:667-669. 10.1038/333667a0.
14. Huizinga T.W., Kleijer M., Tetteroo P.A., Roos D., von dem Borne A.E. Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16). Blood 1990, 75:213-217.
15. Meknache N., Jönsson F., Laurent J., Guinnepain M.-T., Daëron M. Human basophils express the glycosylphosphatidylinositol-anchored low-affinity IgG receptor FcgammaRIIIB (CD16B). J.Immunol. 2009, 182:2542-2550. 10.4049/jimmunol.0801665.
16. Warmerdam P.A., Nabben N.M., van de Graaf S.A., van de Winkel J.G., Capel P.J. The human low affinity immunoglobulin G Fc receptor IIC gene is a result of an unequal crossover event. J.Biol. Chem. 1993, 268:7346-7349.
17. Veri M.-C., Gorlatov S., Li H., Burke S., Johnson S., Stavenhagen J., et al. Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization. Immunology 2007, 121:392-404. 10.1111/j.1365-2567.2007.02588.x.
18. Breen's W.B., van Mirre E., Bruin M., Geissler J., de Boer M., Peters M., et al. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood 2008, 111:1029-1038. 10.1182/blood-2007-03-079913.
19. Breunis W.B., van Mirre E., Geissler J., Laddach N., Wolbink G., van der Schoot E., et al. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum. Mutat. 2009, 30:E640-E650. 10.1002/humu.20997.
20. Niederer H.A., Willcocks L.C., Rayner T.F., Yang W., Lau Y.L., Williams T.N., et al. Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum. Mol. Genet. 2010, 19:3282-3294. 10.1093/hmg/ddq216.
21. Van Schie R.C., Wilson M.E. Evaluation of human FcgammaRIIA (CD32) and FcgammaRIIIB (CD16) polymorphisms in Caucasians and African-Americans using salivary DNA. Clin. Diagn. Lab. Immunol. 2000, 7:676-681.
22. Rollin J., Pouplard C., Cheng Sung H., Leroux D., Saada A., Gouilleux-Gruart V., et al. Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2. Blood 2015, 10.1182/blood-2014-09-594515.
23. Floto R.A., Clatworthy M.R., Heilbronn K.R., Rosner D.R., MacAry P.A., Rankin A., et al. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat. Med. 2005, 11:1056-1058. 10.1038/nm1288.
24. Salmon J.E., Edberg J.C., Kimberly R.P. Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J.Clin. Invest. 1990, 85:1287-1295. 10.1172/JCI114566.
25. Van der Heijden J., Nagelkerke S., Zhao X., Geissler J., Rispens T., van den Berg T.K., et al. Haplotypes of FcγRIIa and FcγRIIIb polymorphic variants influence IgG-mediated responses in neutrophils. J.Immunol. 2014, 10.4049/jimmunol.1203570.
26. Bux J., Stein E.L., Bierling P., Fromont P., Clay M., Stroncek D., et al. Characterization of a new alloantigen (SH) on the human neutrophil Fc gamma receptor IIIb. Blood 1997, 89:1027-1034.
27. Su K., Li X., Edberg J.C., Wu J., Ferguson P., Kimberly R.P. Apromoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. II. Differential binding of GATA4 and Yin-Yang1 transcription factors and correlated receptor expression and function. J.Immunol. 2004, 172:7192-7199.
28. Su K., Wu J., Edberg J.C., Li X., Ferguson P., Cooper G.S., et al. Apromoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J.Immunol. 2004, 172:7186-7191.
29. Van der Heijden J., Breunis W.B., Geissler J., de Boer M., van den Berg T.K., Kuijpers T.W. Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles. J.Immunol. 2012, 188:1318-1324. 10.4049/jimmunol.1003945.
30. Morris D.L., Roberts A.L., Witherden A.S., Tarzi R., Barros P., Whittaker J.C., et al. Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus. Eur. J. Hum. Genet. 2010, 18:1027-1031. 10.1038/ejhg.2010.56.
31. Thabet M.M., Huizinga T.W.J., Marques R.B., Stoeken-Rijsbergen G., Bakker A.M., Kurreeman F.A., et al. Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis. Ann. Rheum. Dis. 2009, 68:1775-1780. 10.1136/ard.2008.099309.
32. Chiriac M.T., Roesler J., Sindrilaru A., Scharffetter-Kochanek K., Zillikens D., Sitaru C. NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J.Pathol. 2007, 212:56-65. 10.1002/path.2157.
33. Liu Z., Shipley J.M., Vu T.H., Zhou X., Diaz L.A., Werb Z., et al. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J.Exp. Med. 1998, 188:475-482.
34. Liu Z., Shapiro S.D., Zhou X., Twining S.S., Senior R.M., Giudice G.J., et al. Acritical role for neutrophil elastase in experimental bullous pemphigoid. J.Clin. Invest. 2000, 105:113-123. 10.1172/JCI3693.
35. Liu Z., Zhou X., Shapiro S.D., Shipley J.M., Twining S.S., Diaz L.A., et al. The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 invivo. Cell 2000, 102:647-655.
36. Shimanovich I., Mihai S., Oostingh G.J., Ilenchuk T.T., Bröcker E.-B., Opdenakker G., et al. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J.Pathol. 2004, 204:519-527. 10.1002/path.1674.
37. Sitaru C., Kromminga A., Hashimoto T., Bröcker E.B., Zillikens D. Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am. J. Pathol. 2002, 161:301-311.
38. Yu X., Holdorf K., Kasper B., Zillikens D., Ludwig R.J., Petersen F. FcγRIIA and FcγRIIIB are required for autoantibody-induced tissue damage in experimental human models of bullous pemphigoid. J.Invest. Dermatol. 2010, 130:2841-2844. 10.1038/jid.2010.230.
39. Payne A.S., Ishii K., Kacir S., Lin C., Li H., Hanakawa Y., et al. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J.Clin. Invest. 2005, 115:888-899. 10.1172/JCI24185.
40. Takahashi Y., Patel H.P., Labib R.S., Diaz L.A., Anhalt G.J. Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes. J.Invest. Dermatol. 1985, 84:41-46.
41. Waschke J., Spindler V. Desmosomes and extradesmosomal adhesive signaling contacts in pemphigus. Med. Res. Rev. 2014, 10.1002/med.21310.
42. Krawczak M., Nikolaus S., von Eberstein H., Croucher P.J.P., El Mokhtari N.E., Schreiber S. PopGen: population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet. 2006, 9:55-61. 10.1159/000090694.
43. Nebel A., Croucher P.J.P., Stiegeler R., Nikolaus S., Krawczak M., Schreiber S. No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:7906-7909. 10.1073/pnas.0408670102.
44. Recke A., Trog L.M., Pas H.H., Vorobyev A., Abadpour A., Jonkman M.F., et al. Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering exvivo. J.Immunol. 2014, 193:1600-1608. 10.4049/jimmunol.1400160.
45. Recke A., Sitaru C., Vidarsson G., Evensen M., Chiriac M.T., Ludwig R.J., et al. Pathogenicity of IgG subclass autoantibodies to type VII collagen: induction of dermal-epidermal separation. J.Autoimmun. 2010, 34:435-444. 10.1016/j.jaut.2009.11.003.
46. Burkett K., McNeney B., Graham J. Anote on inference of trait associations with SNP haplotypes and other attributes in generalized linear models. Hum. Hered. 2004, 57:200-206. 10.1159/000081447.
47. Recke A., Recke K.-G., Ibrahim S., Möller S., Vonthein R. Hardy-Weinberg equilibrium revisited for inferences on genotypes featuring allele and copy-number variations. Sci. Rep. 2015, 5:9066. 10.1038/srep09066.
48. Koch K.-R. Einführung in die Bayes-Statistik 2000, Springer, Berlin; New York.
49. Gessner J.E., Grussenmeyer T., Kolanus W., Schmidt R.E. The human low affinity immunoglobulin G Fc receptor III-A and III-B genes. Molecular characterization of the promoter regions. J.Biol. Chem. 1995, 270:1350-1361.
50. Igl B.-W., Konig I.R., Ziegler A. What do we mean by "replication" and "validation" in genome-wide association studies?. Hum. Hered. 2009, 67:66-68. 10.1159/000164400.
51. Rock B., Labib R.S., Diaz L.A. Monovalent Fab'immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice. J.Clin. Invest. 1990, 85:296-299. 10.1172/JCI114426.
52. Anhalt G.J., Till G.O., Diaz L.A., Labib R.S., Patel H.P., Eaglstein N.F. Defining the role of complement in experimental pemphigus vulgaris in mice. J.Immunol. 1986, 137:2835-2840.
53. Li X., Wu J., Ptacek T., Redden D.T., Brown E.E., Alarcón G.S., et al. Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses. Sci. Transl. Med. 2013, 5. 216ra175. 10.1126/scitranslmed.3007097.
54. Olsson L.M., Holmdahl R. Copy number variation in autoimmunity - importance hidden in complexity?. Eur. J. Immunol. 2012, 42:1969-1976. 10.1002/eji.201242601.
55. Weisenseel P., Martin S., Partscht K., Messer G., Prinz J.C. Relevance of the low-affinity type of the Fcgamma-receptor IIIa-polymorphism in bullous pemphigoid. Arch. Dermatol. Res. 2007, 299:163-164. 10.1007/s00403-007-0755-8.
56. Li N., Aoki V., Hans-Filho G., Rivitti E.A., Diaz L.A. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J.Exp. Med. 2003, 197:1501-1510. 10.1084/jem.20022031.
57. Korn J.M., Kuruvilla F.G., McCarroll S.A., Wysoker A., Nemesh J., Cawley S., et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat. Genet. 2008, 40:1253-1260. 10.1038/ng.237.
58. Rue H., Martino S., Chopin N. Approximate Bayesian inference for latent Gaussian models using integrated nested Laplace approximations (with discussion). JRSS 2009, 71:319-392.
59. Tikhonov A.N. Solutions of Ill-Posed Problems 1977, Distributed Solely by Halsted Press, Washington: New York: Winston.